Swiss Center for Regenerative Medicine

The Swiss Center for Regenerative Medicine (SCRM) comprises the emerging interdisciplinary field of research and clinical applications focused on tissue engineering and cell-based therapies. The goal is to apply the principles of regenerative medicine and technologies to “next generation therapies”.

The SCRM is located at the University Hospital and the University of Zurich integrated into the Center for Clinical Research (CCR). As an interdisciplinary translational research center and core facility for “Good Manufacturing Practice” (GMP), the SCRM aims at the efficient translation of basic biomedical research to applied regenerative therapies. As such, the SCRM enables the integration of various basic science and clinical research activities, including developmental biology, cell biology, stem cell biology, tissue engineering, biomedical engineering and biomaterial science. A combination of approaches such as gene therapy, stem cell transplantation, macro and micro-scale tissue engineering, functionalized biomaterials, and the reprogramming of cell and tissue types is utilized.

The enrollment of clinical studies in the field of regenerative medicine and technologies according to Good Clinical Practice (GCP) is undertaken in collaboration with Swissmedic and the related international authorities (e.g. EMA, FDA) and fostered by the Clinical Trial Center of the CCR.

The SCRM aspires to be the premier Swiss focus for research, training and technology transfer in regenerative medicine.

Contact:
Prof. Dr. med. Dr. rer. nat. S. P. Hoerstrup Head, SCRM University Hospital and University Zurich Moussonstrasse 13 CH-8091 Zurich, Switzerland Tel.: +41 (0)44 255 38 01 or +41 (0)44 634 56 09 Fax: +41 (0)44 634 56 08 E-mail: scrm@usz.ch www.scrm.uzh.ch